SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as investors rally behind its progress on the Tonopah Flats Lithium Project, highlighted by the completion of critical NEPA baseline studies. The community is buzzing with excitement, envisioning a future where ABAT becomes a key player in domestic lithium production. Bullish sentiment is fueled by the company's advancements and the broader narrative of securing American mineral independence.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending as investors discuss upcoming PR and speculate on potential catalysts, with some community members anticipating a rise to \$100. Conversations also highlight partnerships and long-term potential, while others urge caution, citing liquidity and possible pullbacks. Overall, the stock is gaining attention amid excitement surrounding its technology and future prospects in the satellite communications sector.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors discuss a potential short squeeze fueled by high short interest and backing from Google in the AI data center space. Community members are closely watching the stock's ability to break through a key resistance level, with some drawing comparisons to other AI data center plays and anticipating significant upside if it succeeds. Analyst ratings and new partnerships are also contributing to the bullish sentiment.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending due to news of its progress supporting NVIDIA's next-gen AI factory computing platforms, sparking excitement around its role in AI infrastructure. The community is discussing a potential short squeeze, collaboration with NVDA and long-term potential, with some dismissing a recent analyst downgrade. Some are comparing NVTS to other AI-related stocks and highlighting its energy efficiency.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is seeing considerable movement as traders react to a mix of economic signals and geopolitical tensions, with many noting a strong intraday recovery. The community is actively discussing whether the market's resilience is sustainable, pointing to factors like Federal Reserve policy and potential impacts from trade relations. Bullish sentiment is growing amidst the volatility, while bears remain cautious.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to a potential short squeeze setup, fueled by its low float and increased volume. Community discussions revolve around the stock's momentum and potential for significant gains, while some caution against the company's fundamentals and past dilution. The stock is also gaining attention within the broader context of rare earth metal recycling and reshoring efforts.

American Resources Corp. engages in the extraction, processing, transportation, and distribution of metallurgical coal to the steel industry. It focuses on the operation of coal mining complexes located primarily within Pike, Knott, and Letcher Counties, Kentucky, and Wyoming County, West Virginia. The company was founded in 2006 and in headquartered in Fishers, IN.

American Resources Corporation - Ordinary Shares - Class A

American Resources Corporation is trending as investors discuss its potential in the rare earth sector and upcoming ReElement IPO, while some express concerns about valuation and potential dilution; the community is weighing positive catalysts against short-term risks, with some eyeing price targets while others highlight potential government backing.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

BITF is trending as investors discuss its potential in AI and HPC, alongside its existing Bitcoin mining operations; some are drawing comparisons to other high-flying stocks in the sector. The community is excited about the company's future prospects, with some anticipating a short squeeze and significant price appreciation. Recent news and positive analyst ratings may also be contributing to the increased interest.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors discuss its profit potential and upcoming earnings report amidst community speculation about future missions. Bullish sentiment seems to be fueled by comparisons to other space sector stocks like ASTS and RKLB, while some traders are actively shorting LUNR, contributing to volatility.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant movement, with community members pointing to a potential short squeeze as a key factor. The stock is also getting attention after being ranked #7 on IBD's list of fastest-growing companies. Optimism is fueled by upcoming earnings and speculation around major contracts, particularly with McDonald's.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Small Drug Stocks to Buy as the Industry Shows Some Recovery

Innovation is at its peak in the Zacks Medical-Drugs industry. AKBA, IRWD, PYXS, CRDL and PSTV may prove to be good additions to one's portfolio.

Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

Ironwood shares jump 9.3% as second-quarter earnings and revenues top estimates. The company maintains its 2025 outlook.

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?

Ironwood Pharmaceuticals shares dropped 14.6% on Wednesday after the company reported a steep revenue miss in the first quarter, attributing the shortfall to a timing shift in rebates related to its gastrointestinal drug Linzess.&nbsp;The company maintained its full-year guidance and noted progress on a strategic review and pipeline development.The stock closed at $0.79, down $0.13 on Wednesday, and remained flat in after-hours trading.Ironwood posted Q1 2025 revenue of $41.1 million, down from $74.9 million a year earlier and well below the $56.7 million consensus estimate.&nbsp;GAAP net loss widened to $37.4 million, or $0.23 per share, compared to $0.03 per share in the year-ago quarter. Non-GAAP net loss came in at $0.14 per share.The company attributed the revenue decline to a change in gross-to-net rebate reserve estimates from partner AbbVie, which impacted the phasing of&nbsp;Linzess's U.S. net sales but is not expected to affect full-year results.&nbsp;Collaboration revenue related to Linzess dropped 46% year-over-year to $38.8 million.Ironwood reaffirmed its 2025 U.S. Linzess net sales forecast of $800 million to $850 million and raised its adjusted EBITDA outlook to over $105 million.&nbsp;Prescription demand for Linzess rose 8% year-over-year in Q1, in line with expectations. The company ended the quarter with $108.5 million in cash and cash equivalents, up from $88.6 million at year-end.Management said it will focus on maximizing shareholder value, including through a planned confirmatory Phase 3 trial for apraglutide and an ongoing strategic alternatives review with Goldman Sachs.Analyst sentiment soured as Wells Fargo downgraded the company to 'Equalweight' from 'Overweight,' slashing its price target from $7 to $1, according to Koyfin.Similarly, Jefferies downgraded Ironwood to 'Hold' from 'Buy,' lowering its target from $8 to $0.70, Koyfin data said.&nbsp;On Stocktwits, sentiment was ‘bearish’ amid ‘normal’ message volume.&nbsp;Some users criticized the lack of an earnings call, with one remarking that the company simply dropped the earnings release without discussion — a departure from its decade-long tradition — and instead chose to present at a life sciences conference later in the day.&nbsp;<stembedurl>https://stocktwits.com/TeeMan123/message/613768926</stembedurl><stembedurl>https://stocktwits.com/TeeMan123/message/613804225</stembedurl>Another user noted there was little new information in the earnings release beyond what had already been disclosed on April 25,&nbsp;saying they took advantage of the post-earnings selloff to add shares at a 12% discount.<stembedurl>https://stocktwits.com/Bio_Invest101/message/613802455</stembedurl>Shares of Ironwood have fallen 81.7% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call

The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves. 

Equity

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday...

Millrose Properties Set to Join S&P SmallCap 600

Millrose Properties Set to Join S&P SmallCap 600 Millrose Properties Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 5, 2025 NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Millrose Properties Inc...

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$1.51
Prev Close	$1.48
Open	$1.48
Dividend Yield	0.00%
50-Day Moving Average	$1.25
Beta	0.65
Avg. Volume	1.37M
PE Ratio	-28.30

52-Week High	$5.13
52-Week Low	$0.5271
Market Capitalization	$240.4M
EPS (Annual)	$0.0055
Price to Book	-0.78
Revenue Per Employee	$1.39M
Enterprise Value/EBITDA	N/A

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IRWD News

IRWDIronwood Pharmaceuticals Inc - Ordinary Shares - Class A